Medical device maker Dexcom topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring systems.

Get key insights from DexCom’s Q3 2025 earnings: robust revenue growth, new product launches, updated guidance, and future opportunities.

However, the company's financial results have been pretty strong. And if DexCom can keep that up in its next quarterly update ...

Thank you, operator, and welcome to DexCom's Third Quarter 2025 Earnings Call. Our agenda begins with Jake Leach, DexCom's President and Interim CEO, who will summarize our recent highlights and ...

Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 6% in the afternoon session after investor ...

Dexcom faces new FDA reports linking its G7 glucose monitor to patient deaths as lawsuits and regulatory scrutiny intensify.

DexCom, Inc. DXCM is scheduled to report third-quarter 2025 resultson Oct. 30, after the closing bell. In the last reported ...

ViCentra announced today that it appointed former Dexcom and Medtronic Diabetes leaders to new executive roles.

The medtech ecosystem is an ever-evolving one around the world, and Ireland serves as one of the more interesting pieces of ...

Bernard Jackman believes Connacht should do everything they can to bring Joey Carbery back to Irish rugby, and has called on the IRFU to support the move financially.

Amid some scrutiny over its latest-generation G7 CGM, Dexcom officials addressed claims on the company's latest earnings call ...